Security key
61225M102
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)
CUSIP: 61225M102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 84,039,109
- Total 13F shares
- 49,754,753
- Share change
- +3,376,892
- Total reported value
- $263,674,421
- Put/Call ratio
- 22%
- Price per share
- $5.30
- Number of holders
- 80
- Value change
- +$18,158,687
- Number of buys
- 52
- Number of sells
- 18
Report period
Q3 2024
Institutions
80
Top holders
10
GLUE full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Monte Rosa Therapeutics, Inc. SEC filings
Monte Rosa Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61225M102
Recent filing periods:
Top shareholders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
9.2%
|
7,692,298
|
$28,769,195 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
7.1%
|
5,977,587
|
$22,357,000 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
6.1%
|
5,094,974
|
$19,055,203 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.8%
|
4,916,095
|
$18,386,195 | — | 30 Jun 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
5.4%
|
4,535,000
|
$16,960,900 | — | 30 Jun 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.2%
|
2,659,000
|
$9,944,660 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
2,547,075
|
$9,526,061 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
2,360,093
|
$8,826,748 | — | 30 Jun 2024 | |
| Aisling Capital Management LP |
13F
|
Company |
1.8%
|
1,472,331
|
$5,506,518 | — | 30 Jun 2024 | |
| Alphabet Inc. |
13F
|
Company |
1.7%
|
1,464,015
|
$5,475,416 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
995,943
|
$3,724,827 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.1%
|
890,000
|
$3,328,600 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
847,442
|
$3,169,853 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.76%
|
636,084
|
$2,378,954 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.45%
|
375,000
|
$1,402,500 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
311,800
|
$1,166,132 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.37%
|
307,319
|
$1,149,000 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
294,196
|
$1,100,293 | — | 30 Jun 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.31%
|
261,014
|
$976,192 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
254,714
|
$952,630 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
193,696
|
$724,423 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.2%
|
166,671
|
$623,350 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.18%
|
153,758
|
$575,055 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
109,864
|
$410,892 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.12%
|
102,709
|
$384,132 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.12%
|
98,557
|
$366,000 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
92,349
|
$345,386 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.11%
|
89,096
|
$333,219 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.08%
|
68,503
|
$256,201 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
68,342
|
$255,599 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
67,746
|
$253,370 | — | 30 Jun 2024 | |
| Sarasin & Partners LLP |
13F
|
Company |
0.08%
|
65,081
|
$243,403 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.06%
|
49,410
|
$184,793 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
47,925
|
$179,228 | — | 30 Jun 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.05%
|
45,500
|
$170,170 | — | 30 Jun 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.05%
|
41,917
|
$156,770 | — | 30 Jun 2024 | |
| Long Corridor Asset Management Ltd |
13F
|
Company |
0.05%
|
40,000
|
$149,600 | — | 30 Jun 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.04%
|
35,686
|
$133,466 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.04%
|
32,780
|
$122,597 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
25,346
|
$95,000 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.03%
|
23,422
|
$87,598 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
23,294
|
$87,120 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
22,665
|
$84,767 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
20,928
|
$78,271 | — | 30 Jun 2024 | |
| Castleview Partners, LLC |
13F
|
Company |
0.02%
|
18,950
|
$70,873 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
16,566
|
$61,957 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
16,394
|
$61,314 | — | 30 Jun 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
16,338
|
$61,104 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
16,308
|
$60,992 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
16,270
|
$60,850 | — | 30 Jun 2024 |
Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) as of Q3 2024
As of 30 Sep 2024,
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,754,753 shares.
The largest 10 holders included
NEA Management Company, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc., SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Aisling Capital Management LP, and Alphabet Inc..
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
73
Q3 2024 holders
80
Holder diff
7
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.